Wockhardt Limited, the Pharmaceutical and Biotechnology major, reported its 3rd quarter results for Financial Year 2024-25. The company reported a net profit of Rs. 20 crore for its quarter ended December 31, 2024 as compared to net loss of Rs. 86 crore during the corresponding quarter previous fiscal year.

Wockhardt also saw its revenue from operations increased 3% to Rs. 721 crore during Q3 FY25.  The revenue from operations stood at Rs. 701 crore in Q3FY24.

Wockhardt’s EBITDA for December quarter zoomed 246% year-on-year (YoY) to Rs. 128 crore as against Rs. 37 crore in Q3FY24.